Rubius Therapeutics, Inc. RUBY NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Rubius Therapeutics, Inc. (RUBY), 포함 32 건 매수 및 15 건 매도. 내부자 매수 총액은 $7.01M 내부자 매도 총액은 $2.46M.

최근 활동이 있는 주요 내부자에는 Appelhans Dannielle, Cagnoni Pablo J, Turka Laurence A.. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — RUBY

날짜	이름	직책	거래 유형	주식수	평균 가격	금액	보유 주식수
2023-02-24	Appelhans Dannielle	CEO and President	정보 매도	10,385	$0.13	$1.32K	-
2023-02-01	Cagnoni Pablo J	Director	정보 매도	8,448	$0.25	$2.11K	66,082
2023-02-01	Appelhans Dannielle	CEO and President	정보 매도	3,878	$0.25	$969.50	10,385
2023-01-31	Cagnoni Pablo J	Director	정보 매도	7,240	$0.24	$1.74K	74,530
2023-01-31	Turka Laurence A.	Chief Scientific Officer	정보 매도	2,593	$0.24	$622.32	18,391
2023-01-31	Appelhans Dannielle	CEO and President	옵션 행사	7,500	-	-	14,263
2023-01-29	Cagnoni Pablo J	Director	옵션 행사 (매도)	21,250	-	-	42,500
2023-01-29	Turka Laurence A.	Chief Scientific Officer	옵션 행사	7,438	-	-	12,359
2022-08-09	Appelhans Dannielle	Chief Operating Officer	정보 매도	5,737	$0.80	$4.59K	6,763
2022-07-29	Schaffert Susanne	Director	RSU 부여	50,000	-	-	50,000
2022-07-12	Schaffert Susanne	Director	알 수 없음	-	-	-	-
2022-05-12	Afeyan Noubar	10 Percent Owner	RSU 부여	25,000	$1.24	$31K	25,000
2022-05-12	Epstein David R	Director	RSU 부여	499,762	-	-	499,762
2022-05-12	Rosenblatt Michael	Director	RSU 부여	25,000	$1.24	$31K	25,000
2022-05-12	Cuss Francis M	Director	RSU 부여	25,000	$1.24	$31K	25,000
2022-05-12	Sohn Catherine A.	Director	RSU 부여	25,000	$1.24	$31K	25,000
2022-05-12	Holles Natalie C.	Director	RSU 부여	25,000	$1.24	$31K	25,000
2022-05-12	Symonds Jonathan	Director	RSU 부여	25,000	$1.24	$31K	25,000
2022-05-12	Prener Anne	Director	RSU 부여	25,000	$1.24	$31K	25,000
2022-04-21	Epstein David R	Director	정보 매수	30,000	$1.44	$43.33K	4,720,012
2022-02-01	Cagnoni Pablo J	CEO and President	정보 매도	6,730	$6.57	$44.24K	35,520
2022-02-01	Keson-brookes Maiken	CLO & Corp. Secretary	정보 매도	2,732	$6.57	$17.96K	5,343
2022-02-01	Turka Laurence A.	Chief Scientific Officer	정보 매도	2,517	$6.57	$16.54K	4,921
2022-01-31	Cagnoni Pablo J	CEO and President	RSU 부여	100,000	-	-	100,000
2022-01-31	Carmona Jose	Chief Financial Officer	RSU 부여	34,500	-	-	34,500
2022-01-31	Keson-brookes Maiken	CLO & Corp. Secretary	RSU 부여	34,500	-	-	34,500
2022-01-31	Turka Laurence A.	Chief Scientific Officer	RSU 부여	34,500	-	-	34,500
2022-01-31	Appelhans Dannielle	Chief Operating Officer	RSU 부여	30,000	-	-	30,000
2022-01-29	Cagnoni Pablo J	CEO and President	옵션 행사	21,250	-	-	42,250
2022-01-29	Keson-brookes Maiken	CLO & Corp. Secretary	옵션 행사	8,075	-	-	8,075
2022-01-29	Turka Laurence A.	Chief Scientific Officer	옵션 행사	7,438	-	-	7,438
2021-12-31	Cagnoni Pablo J	CEO and President	알 수 없음	-	-	-	-
2021-08-31	Appelhans Dannielle	Chief Operating Officer	RSU 부여	50,000	-	-	50,000
2021-08-09	Appelhans Dannielle	Officer	알 수 없음	-	-	-	-
2021-05-12	Afeyan Noubar	10 Percent Owner	RSU 부여	25,000	$23.25	$581.25K	25,000
2021-05-12	Epstein David R	Director	RSU 부여	27,919	$23.25	$649.12K	27,919
2021-05-12	Rosenblatt Michael	Director	RSU 부여	25,000	$23.25	$581.25K	25,000
2021-05-12	Cuss Francis M	Director	RSU 부여	25,000	$23.25	$581.25K	25,000
2021-05-12	Sohn Catherine A.	Director	RSU 부여	25,000	$23.25	$581.25K	25,000
2021-05-12	Holles Natalie C.	Director	RSU 부여	25,000	$23.25	$581.25K	25,000
2021-05-12	Symonds Jonathan	Director	RSU 부여	25,000	$23.25	$581.25K	25,000
2021-05-12	Prener Anne	Director	RSU 부여	25,000	$23.25	$581.25K	25,000
2021-03-19	Flagship Ventures Fund Iv General Partner Llc	10 Percent Owner	정보 매수	70,000	$29.00	$2.03M	2,633,703
2021-03-15	Keson-brookes Maiken	CLO & Corp. Secretary	정보 매도	25,000	$20.24	$505.97K	-
2021-02-11	Epstein David R	Director	정보 매도	26,704	$14.93	$398.56K	4,690,012
2021-02-10	Epstein David R	Director	정보 매도	7,404	$14.79	$109.53K	4,716,716
2021-02-09	Epstein David R	Director	정보 매도	2,100	$14.83	$31.15K	4,724,120
2021-02-08	Epstein David R	Director	정보 매도	89,233	$14.88	$1.33M	4,726,220
2021-01-29	Cagnoni Pablo J	CEO and President	RSU 부여	85,000	-	-	85,000
2021-01-29	Keson-brookes Maiken	CLO & Corp. Secretary	RSU 부여	32,300	-	-	32,300